Barriers and Facilitators to Primary Care or Human Immunodeficiency Virus Clinics Providing Methadone or Buprenorphine for the Management of Opioid Dependence
Open Access
- 8 August 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 165 (15) , 1769-1776
- https://doi.org/10.1001/archinte.165.15.1769
Abstract
Research from JAMA Internal Medicine — Barriers and Facilitators to Primary Care or Human Immunodeficiency Virus Clinics Providing Methadone or Buprenorphine for the Management of Opioid DependenceThis publication has 25 references indexed in Scilit:
- Regular Outpatient Medical and Drug Abuse Care and Subsequent Hospitalization of Persons Who Use Illicit DrugsJAMA, 2001
- HIV transmission and the cost-effectiveness of methadone maintenanceAmerican Journal of Public Health, 2000
- Methadone maintenance in general practice: impact on staff attitudesIrish Journal of Medical Science, 2000
- Provision of Methadone Treatment in Primary Care Medical PracticesJAMA, 2000
- The cost‐effectiveness of methadone maintenance as a health care interventionAddiction, 1999
- French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphineAddiction, 1998
- Census of Patients Receiving Methadone Treatment in a General PracticeAddiction Research, 1996
- Methadone maintenance in general practice: patients, workload, and outcomesBMJ, 1994
- Mortality in heroin addiction: impact of methadone treatmentActa Psychiatrica Scandinavica, 1990
- Methadone maintenance patients in general medical practice. A preliminary reportJAMA, 1988